세계의 약물 남용(DOA) 검사 시장 보고서(2023년)

“Drugs of Abuse (DOA) Testing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drugs of abuse (doa) testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services

• 2) By Sample Type: Urine; Hair; Oral Fluid; Breath

• 3) By Application: Pain Management; Criminal Justice; Workplace Screening

• 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users

• Companies Mentioned: Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Dragerwerk AG & Co. KGaA; Quest Diagnostics Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the drugs of abuse (doa) testing market are Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc., United States Drug Testing Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Zimmer Biomet, Homology Medicines Inc., and bioMerieux Inc.

The global drugs of abuse (DOA) testing market is expected to grow from $6.03 billion in 2022 to $6.65 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The drugs of abuse (DOA) testing market is expected to reach $9.35 billion in 2027 at a CAGR of 8.9%.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Drug of abuse (DOA) testing refers to the examination of a substance, such as a drug, chemical, or plant product, that is usually treated recreationally. It includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are tested for on a drug panel. The patient's urine, saliva, blood, hair, or sweat are used in this clinical screening procedure.

North America was the largest region in the drugs of abuse(DOA) testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drugs of abuse (DOA) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products and services for drug of abuse (DOA) testing are analyzers, rapid testing devices, consumables, and laboratory services. An analyzer is a device that automatically measures the chemical concentration of one or more components or another associated physical quantity, continuously or intermittently. There are sample types included such as urine, hair, oral fluid, and breat, and are available in various applications such as pain management, criminal justice, and workplace screening. The end users involves hospitals, diagnostic laboratories, forensic laboratories, and others.

Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in June 2021, according to United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders, and over 275 million people used drugs in 2020. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Technology advancement is a key trend gaining popularity in the drugs of abuse (DOA) testing market. Major companies operating in the drugs of abuse (DOA) testing market are focused on developing new technological solutions to strengthen their position in the market. For instance, in May 2020, a Canada-based technology company created instruments to detect THC in breath for law enforcement. Cannabix Technologies' point-of-care breath testing solutions is used for the detection of 9-tetrahydrocannabinol ("THC"), the psychoactive element in marijuana that contributes to impairment, are at the forefront of industry research and development. The THCBA detects THC in breath using microfluidic sensor technology. The THCBA includes appealing features such as single-stage direct breath capabilities and a one-handed ergonomic design. So far, testing has shown that the device can produce results in less than 5 minutes from the time the sample is eaten.

In June 2020, Medix Biochemica, a Finland-based biotechnology company, acquired Biostride Inc. for an undisclosed amount. With this acquisition, Biostride's array of drug of abuse antibodies and antigens is now available to IVD and drug testing customers worldwide. The acquisition is consistent with Medix's plan to streamline the IVD supply chain and emerge as the industry's top provider of vital raw materials. Biostride Inc., a US-based producer of antibodies and antigens for the IVD industry for drugs of abuse and hormone testing.

The countries covered in the drugs of abuse (DOA) testing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Drugs of Abuse (DOA) Testing Market
• 4.2. Ukraine-Russia War Impact On Drugs of Abuse (DOA) Testing Market
• 4.3. Impact Of High Inflation On Drugs of Abuse (DOA) Testing Market

5. Drugs of Abuse (DOA) Testing Market Size And Growth

• 5.1. Global Drugs of Abuse (DOA) Testing Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Drugs of Abuse (DOA) Testing Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Drugs of Abuse (DOA) Testing Market Segmentation

• 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Analyzers
• Rapid Testing Devices
• Consumables
• Laboratory Services
• 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Urine
• Hair
• Oral Fluid
• Breath
• 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Pain Management
• Criminal Justice
• Workplace Screening
• 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories
• Other End Users

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

• 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

• 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

• 9.1. China Drugs of Abuse (DOA) Testing Market Overview
• 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

• 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

• 11.1. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

• 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

• 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

• 14.1. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

• 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
• 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

• 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

• 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

• 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Drugs of Abuse (DOA) Testing Market

• 19.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
• 19.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Drugs of Abuse (DOA) Testing Market

• 20.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Drugs of Abuse (DOA) Testing Market

• 21.1. North America Drugs of Abuse (DOA) Testing Market Overview
• 21.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Drugs of Abuse (DOA) Testing Market

• 22.1. USA Drugs of Abuse (DOA) Testing Market Overview
• 22.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Drugs of Abuse (DOA) Testing Market

• 23.1. South America Drugs of Abuse (DOA) Testing Market Overview
• 23.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Drugs of Abuse (DOA) Testing Market

• 24.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Drugs of Abuse (DOA) Testing Market

• 25.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
• 25.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Drugs of Abuse (DOA) Testing Market

• 26.1. Africa Drugs of Abuse (DOA) Testing Market Overview
• 26.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

• 27.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
• 27.2. Drugs of Abuse (DOA) Testing Market Company Profiles
  • 27.2.1. Abbott Laboratories
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Danaher Corporation
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Laboratory Corporation of America Holdings
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Dragerwerk AG & Co. KGaA
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Quest Diagnostics Inc.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

29. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer